SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed tests (LDTs) based ...
DUBLIN--(BUSINESS WIRE)--The "Optical Genome Mapping Market Size, Share & Trends Analysis Report, By Product (Instruments, Software), By Application (Structural Variant Detection, Genome Assembly), By ...
SAN DIEGO, June 18, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics (NASDAQ: BNGO) recently participated in the European Society of Human Genetics (ESHG) conference held in Milan, Italy, from May 24-27, ...
Dublin, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The "Optical Genome Mapping Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ResearchAndMarkets.com's ...
Optical genome mapping (OGM) was key for the diagnosis of a patient with mediastinal mass and pleural effusion hospitalized in an insensitive care unit at the Hospital Infantil Universitario Niño ...
Technology bridges strain typing and sequencing to correlate phenotype to genotype. Beijing Genomics Institute (BGI) and OpGen have decided to work together to expand the use of the latter’s Optical ...
Optical Genome Mapping for diagnosis of paediatric leukaemia Cytogenetics has led to the discovery of multiple chromosomal anomalies associated with hemato-oncologic diseases in children and ...
SAN DIEGO - Bionano Genomics, Inc. (NASDAQ:BNGO) announced Wednesday that a peer-reviewed study has demonstrated the effectiveness of optical genome mapping (OGM) in detecting genomic alterations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results